What is the emergency management of hyperkalemia (potassium 6.9 mEq/L) in a woman in her late 80s?

Emergency Management of Severe Hyperkalemia (K+ 6.9 mEq/L) in an Elderly Woman

Immediately administer IV calcium gluconate (10 mL of 10% solution) to stabilize cardiac membranes, followed by IV insulin (10 units) with glucose (50 mL dextrose) and nebulized salbutamol (10-20 mg) to shift potassium intracellularly—this combination is more effective than any single agent alone. 1

Immediate Cardiac Protection (Within 1-3 Minutes)

• IV calcium gluconate 10 mL of 10% solution is your first-line intervention
  • Acts within 1-3 minutes to reduce membrane excitability and prevent fatal arrhythmias
  • Does NOT lower serum potassium—it only protects the heart
  • If no effect within 5-10 minutes, repeat the dose 1
  • Critical in elderly patients where cardiac complications are the primary mortality risk

Obtain ECG Immediately

Before proceeding, get an ECG to assess for hyperkalemia-related changes:

• Peaked T waves
• Prolonged QRS complexes
• Important caveat: ECG changes are highly variable and not sensitive—23% of patients with K+ >5.5 show changes, and 45% with K+ >7.0 show peaked T waves or widened QRS 2
• Do not wait for ECG changes to treat—laboratory values take priority in decision-making 1

Shift Potassium Intracellularly (Within 30-60 Minutes)

Deploy these therapies simultaneously for maximum effect:

Insulin + Glucose (Primary Shifting Agent)

• 10 units regular insulin IV + 50 mL dextrose (D50W)
• Onset: 30 minutes
• Critical warning for elderly patients: Hypoglycemia occurred in 6% overall but 17% in patients with K+ >7.0 2
• Monitor glucose closely for 4-6 hours post-administration

Nebulized Beta-Agonist (Synergistic Effect)

• Salbutamol 10-20 mg nebulized (some protocols use 20 mg in 4 mL) 1
• Onset: 30 minutes, peak effect 1-4 hours
• Reduces K+ by 0.62-1.636 mEq/L 3
• Combination with insulin-glucose is more effective than either alone 4
• Common side effects: tachycardia, dizziness (manageable in most patients) 3
• Age consideration: Monitor for cardiac effects, but generally safe even in elderly

Eliminate Potassium from the Body

If Patient Has Residual Kidney Function and Volume Overload

• Loop diuretics (furosemide) to enhance urinary potassium excretion 1
• Only effective if patient is not oliguric

If Patient Has Metabolic Acidosis

• IV sodium bicarbonate promotes potassium excretion through increased distal sodium delivery 1
• Only use if concurrent metabolic acidosis is present—evidence is equivocal otherwise 4

Consider Hemodialysis If:

• Oliguria or end-stage renal disease
• Resistant hyperkalemia despite medical management
• K+ remains dangerously elevated
• Dialysis is the only intervention that normalizes median K+ within 4 hours (median reduction from 6.2 to 3.8 mEq/L) 2

Rule Out Pseudohyperkalemia FIRST

Before treating, confirm this is true hyperkalemia:

• Repeat fist clenching during blood draw causes falsely elevated K+
• Hemolysis from poor phlebotomy technique
• Slow specimen processing
• Plasma K+ is 0.1-0.4 mEq/L lower than serum 1
• If clinically stable with no ECG changes, consider repeating the lab before aggressive treatment

What NOT to Do

• Avoid sodium polystyrene sulfonate (Kayexalate): Not effective within 4 hours, poor tolerance, significant adverse effects, falling out of favor 1, 5
• Do not rely on ECG alone: 77% of hyperkalemic patients had NO ECG changes 2
• Do not use bicarbonate without metabolic acidosis: Evidence is equivocal 4

Expected Timeline and Monitoring

• Median time to treatment in real-world EDs: 2.7 hours—this is too long 2
• Recheck K+ at 0.5,1,2, and 4 hours after initial treatment
• With medications alone (no dialysis), expect median K+ reduction from 6.3 to 5.3 mEq/L within 4 hours 2
• Monitor glucose for hypoglycemia, especially in elderly patients

After Acute Stabilization: Prevent Recurrence

Once K+ is controlled:

• Identify and correct reversible causes (medications, acute kidney injury, metabolic acidosis)
• Evaluate risk of recurrence—one in five patients with CKD, HF, or diabetes will have recurrent hyperkalemia 6
• Consider newer potassium binders (patiromer, sodium zirconium cyclosilicate) for chronic management 6, 7
• Do not discontinue RAASi therapy if indicated—use potassium binders to enable continuation of life-saving medications 6, 1
• Recheck K+ within 7-10 days 1

Age-Specific Considerations for Late 80s

• Higher risk of insulin-induced hypoglycemia: Monitor glucose aggressively
• Cardiac protection with calcium is paramount: Elderly have higher baseline cardiovascular risk
• Polypharmacy is common: Review all medications for potassium-elevating drugs (ACEi, ARBs, spironolactone, NSAIDs, trimethoprim)
• Renal function likely reduced: Consider dialysis earlier if oliguria present